Supplement Industry Wants Answers From FDA Transparency Task Force
This article was originally published in The Tan Sheet
Executive Summary
Supplement industry leaders want FDA's Transparency Task Force to shed light on the agency's decision-making process and explain controversial and ambiguous policies as well as improve communication
You may also be interested in...
Information Disclosure Issues Challenge FDA Transparency Task Force
FDA questions whether to disclose information on product applications that a company abandons before approval or in some cases on applications in which review is still pending
Information Disclosure Issues Challenge FDA Transparency Task Force
FDA questions whether to disclose information on product applications that a company abandons before approval or in some cases on applications in which review is still pending
Information Disclosure Issues Challenge FDA Transparency Task Force
FDA questions whether to disclose information on product applications that a company abandons before approval or in some cases on applications in which review is still pending